4//SEC Filing
Lipocine Inc. 4
Accession 0001638599-17-000127
$LPCNCIK 0001535955operating
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 9:40 PM ET
Size
5.6 KB
Accession
0001638599-17-000127
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Fink Jeffrey Arvin
Director
Transactions
- Award
Restricted Stock Unit
2017-01-26+7,500→ 7,500 totalExercise: $0.00From: 2017-12-31Exp: 2027-01-25→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit
- [F2]Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021.
Documents
Issuer
Lipocine Inc.
CIK 0001535955
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001535955
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 9:40 PM ET
- Size
- 5.6 KB